Immuneering Corporation — Cash Flow Charts
15 quarters of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-17.4% -$2M
$-14M
Free Cash Flow↓-146.6% -$102K
$-171K
Investing Cash Flow↓-61.6% -$5M
$3M
Financing Cash Flow
$8K
Capex↑+146.6% +$102K
$171K
Stock-Based Comp↑+56.5% +$592K
$2M
D&A↑+16.8% +$13K
$90K
SBC Allocated Expense↑+56.5% +$592K
$2M